Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind multicenter trial of ZY-A001 in children with acute upper respiratory tract infection (exterior-interior excess heat pattern)
CTR20251485Phase 3Completed
- Sponsor
- Yabao Pharmaceutical Group Co., Ltd.
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ZY-A001 in upper respiratory infection (URI), sponsored by Yabao Pharmaceutical Group Co., Ltd.. Started May 2025; status: completed.
02
Drugs
ZY-A001
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on CTR20251485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251485.